{"database": "lobbying", "table": "lobbying_activities", "rows": [[3188466, "9528d989-d284-41c6-b726-dbfa319dd149", "Q2", "THE LIAISON GROUP, LLC", 401104378, "NATIONAL CANNABIS ROUNDTABLE", 2024, "second_quarter", "CSP", "Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 65500, null, 0, 0, "2024-07-11T09:53:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3188466"], "units": {}, "query_ms": 11.62437698803842, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}